,11,14 It has been demonstrated that ATRX is frequently mutated in a variety of tumors including MYCN amplified neuroblastoma,11 gliomas,15 neuroendocrine neoplasms16 and sarcomas.17 Here, MYCN is linked to neuroblastoma.